Valneva fait un point sur l’utilisation du vaccin IXCHIQ® au Royaume-Uni Lyon (France), le 13 février 2026 – (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui qu’à la suite d’une revue des bénéfices et risques du vaccin contre le chikungunya de la société, IXCHIQ®, la Commission britannique des médicaments à usage humain (CHM) a mis à jour ses recommandations concernant l’utilisation de ce vaccin. Les informations de prescription (PI) mises à jour refléteront ces recommandations, qui incluent désormais une restriction pour les personnes de...
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom Lyon (France), February 13, 2026 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that following a review of the benefits and risks of the Company’s single‑dose chikungunya vaccine, IXCHIQ®, the United Kingdom’s (UK) Commission on Human Medicines (CHM) has updated its recommendations for use of the vaccine. The updated Prescribing Information (PI) will reflect these recommendations, which now include a restriction for individuals over 60 years of age, for people with sp...
A director at Voestalpine AG sold 517 shares at 44.220EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
VALNEVA Declaration of shares and voting rights: January 31, 2026 VALNEVA Declaration of shares and voting rights January 31, 2026__________________________________________________________________________________________ Company name: VALNEVARegistered office: Îlot Saint-Joseph Bureaux Convergence – Bât. A, 12 ter Quai Perrache – 69002 LyonRegulated market of Euronext Paris - Compartment B Declaration date: correction as of February 11, 2026 Number of shares composing the share capital of ValnevaTotal number of voting rights including suspended voting rights*Description of the change D...
VALNEVA Déclaration d’actions et de droits de vote : 31 janvier 2026 VALNEVA Déclaration d’actions et de droits de vote 31 janvier 2026__________________________________________________________________________________________ Dénomination sociale : VALNEVAAdresse du siège social : Îlot Saint-Joseph Bureaux Convergence – Bât. A, 12 ter Quai Perrache – 69002 Lyon Marché réglementé Euronext Paris - Compartiment B Date de la déclaration : correctif au 11 février 2026 Nombre d’actions composant le capital de ValnevaNombre total de droits de vote incluant les droits de vote suspendus*Origin...
AMS Osram released its Q4 and FY 2025 numbers yesterday. The Q4 performance was soft but outperformed our and the street's expectations, and was well above the mid-point of guidance, thanks to a robust aftermarket business. Positively, pro-forma net leverage (company methodology) dropped to 2.5x. While 2026 is expected to be a transition year, credit stats should improve substantially from 2027 onwards. We believe the bonds offer broadly fair value.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.